United Therapeutics Corporation Analysis
| Analyst Ratings |
|
Average Target Price
|
285.50
|
|
Average Rating
|
4.00
|
|
# Strong Buys
|
7
|
|
# Buys
|
4
|
|
# Holds
|
1
|
|
# Sells
|
3
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
3.89
|
4.91
|
1.02
|
26.22%
|
|
2022-06-30
|
4.13
|
2.41
|
-1.72
|
-41.65%
|
|
2022-03-31
|
3.35
|
5.03
|
1.68
|
50.15%
|
|
2021-12-31
|
3.72
|
2.35
|
-1.37
|
-36.83%
|
|
2021-09-30
|
3.59
|
3.42
|
-0.17
|
-4.74%
|
|
2021-06-30
|
3.02
|
3.65
|
0.63
|
20.86%
|
|
2021-03-31
|
2.94
|
0.61
|
-2.33
|
-79.25%
|
|
2020-12-31
|
3.14
|
2.19
|
-0.95
|
-30.25%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
12.35
|
|
2021-12-31
|
10.03
|
|
2020-12-31
|
11.56
|
|
2019-12-31
|
-2.45
|
|
2018-12-31
|
13.45
|
|
2017-12-31
|
9.34
|
|
2016-12-31
|
15.22
|
|
2015-12-31
|
12.89
|
|
2014-12-31
|
6.17
|
|
2013-12-31
|
3.28
|
|
2012-12-31
|
5.27
|
|
2011-12-31
|
3.53
|
|
2010-12-31
|
1.75
|
|
2009-12-31
|
0.36
|
|
2008-12-31
|
-0.92
|
|
2007-12-31
|
0.72
|
|
2006-12-31
|
1.29
|
|
2005-12-31
|
1.29
|
|
2004-12-31
|
0.33
|
|
2003-12-31
|
-0.22
|
|
2002-12-31
|
-0.42
|
|
2001-12-31
|
-0.92
|
|
2000-12-31
|
-0.92
|
|
1999-12-31
|
-0.75
|